Anthropic says its Claude AI helped uncover previously unknown enzyme system that may enable new gene editing
- ID
- 28019
- Status
- summarized
- Published
- 24 Sep 2026, 11:16 AM
- Fetched
- 24 Sep 2026, 11:54 AM
- Provider
- Malay Mail Tech
- Category
- malaysia-tech
- Original URL
- https://www.malaymail.com/news/tech-gadgets/2026/09/24/anthropic-says-its-claude-ai-helped-uncover-previously-unknown-enzyme-system-that-may-enable-new-gene-editing/236311
- Source URL
- https://www.malaymail.com/feed/rss/tech-gadgets
Summary
- Score
- 4.0
- Created
- 24 Sep 2026, 11:54 AM
- Tags
- Audience
- ai_ml_learnersai_agent_users
What happened
Anthropic announced the first discovery from its own molecular biology lab: it says its Claude model flagged a previously unknown enzyme system, which the company calls ART, that resembles CRISPR. According to the report, preliminary tests suggest ART could be programmable like CRISPR for gene editing, but its function is still unknown and the work has not been peer-reviewed.
Why it matters
There is nothing here you can build on yet: the only technical claim is an unconfirmed, non-peer-reviewed finding named ART, announced by the same company that built the model that found it, with no paper, dataset, or benchmark in the text. If you're evaluating AI agents for research pipelines, treat this as a vendor claim to wait on rather than evidence, and look for the peer-reviewed version before citing it to anyone.
Discussion angle
What would actually count as proof that an AI agent made a scientific discovery — and why does a company announcing its own lab's unconfirmed, non-peer-reviewed finding not clear that bar?